Bonesupport Holding AB (BONEX)

Currency in SEK
228.60
+2.40(+1.06%)
Real-time Data·
Advertisement
BONEX is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
225.00229.60
52 wk Range
165.00323.00
Key Statistics
Prev. Close
226.2
Open
228
Day's Range
225-229.6
52 wk Range
165-323
Volume
60.19K
Average Volume (3m)
221K
1-Year Change
-20.7207%
Book Value / Share
14.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BONEX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
356.58
Upside
+55.99%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Bonesupport Holding AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 356.58
(+55.99% Upside)

Bonesupport Holding AB Earnings Call Summary for Q2/2026

  • Q2 net sales rose 30% at constant rates to SEK 356M; adjusted operating margin hit 29% with SEK 67M operating cash flow generated.
  • Full-year 2026 sales growth guidance raised to 33-36% at constant rates, below earlier 40% expectations, pressuring shares down 6.84%.
  • Handful of top U.S. accounts imposed temporary pre-approval restrictions on CERAMENT G usage, slowing growth despite strong underlying demand.
  • CERAMENT V FDA De Novo responses expected by end-August; approval would create new category but won't materially impact 2026 results.
  • Company ended quarter with SEK 434M cash, repurchased SEK 83M in shares; tariffs and inventory write-downs pressured gross margin to 93.8%.
Last Updated: 16/07/2026, 10:04
Read Full Transcript

Earnings

Latest Release
16/07/2026
EPS / Forecast
1.23 / 1.13
Revenue / Forecast
356M / 362.42M
EPS Revisions
Last 90 days

Compare BONEX to Peers and Sector

Metrics to compare
BONEX
Peers
Sector
Relationship
P/E Ratio
69.6x−9.6x−0.3x
PEG Ratio
1.56−0.200.00
Price/Book
15.7x2.6x2.6x
Price / LTM Sales
11.6x9.5x3.1x
Upside (Analyst Target)
59.9%156.6%48.5%
Fair Value Upside
Unlock−3.2%6.3%Unlock

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Employees
171
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.11M25.98%3.87B
Other Institutional Investors
22.62M34.35%5.12B
Public Companies & Retail Investors
26.12M39.67%5.91B
Total
65.86M100.00%14.9B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Swedbank Robur Fonder AB9.16%6,035,4971,365,229
SMALLCAP World Fund, Inc.5.38%3,544,651801,800

People Also Watch

633.00
CAMX
+0.32%
159.00
ALIFb
+0.76%
100.20
HEM
-0.60%
13.485
EUZG
+0.56%

FAQ

What Is the Bonesupport (Stockholm: BONEX) Share Price Today?

The Bonesupport stock price today is 228.60 SEK.

What Stock Exchange Does Bonesupport (BONEX) Trade On?

Bonesupport is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Bonesupport?

The stock symbol (also called a 'ticker') for Bonesupport is "BONEX."

What Is the Current Bonesupport Market Capitalisation?

As of today, Bonesupport (Stockholm: BONEX) market cap is 15.04B SEK.

What Is Bonesupport's (BONEX) Earnings Per Share (TTM)?

The Bonesupport EPS is currently 3.21 (Trailing Twelve Months).

When Is the Next Bonesupport Earnings Date?

Bonesupport's next earnings report will be released on 22/10/2026.

Is BONEX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bonesupport moving averages and other technical indicators, the daily buy/sell signal for BONEX stock is Strong Buy.

How Many Times Has Bonesupport Stock Split?

Bonesupport has split 0 times. (See the BONEX stock split history page for full effective split date and price information.)

How Many Employees Does Bonesupport Have?

Bonesupport has 171 employees, based on their latest Companies House report.

What is the current trading status of Bonesupport (Stockholm: BONEX)?

As of 20/08/2026, Bonesupport (BONEX) is trading at a share price of 228.60 SEK, with a previous close of 226.20 SEK. The stock has fluctuated within a day range of 225.00 SEK to 229.60 SEK, while its 52-week range spans from 165.00 SEK to 323.00 SEK.

What Is Bonesupport (BONEX) Price Target According to Analysts?

The average 12-month price target for Bonesupport is 356.58 SEK, with a high estimate of 416 SEK and a low estimate of 275 SEK. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +55.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.